{
  "id": "cluster_28_doc1",
  "content": "The recent implementation of Policy #NEURO-719 has significantly impacted coverage for experimental neurolinguistic therapy. Providers across the Connecticut network report increased claim denials for patients under 45 with chronic aphasia. The Hartford Clinic noted a 38% reduction in approved claims since March 2024, particularly affecting younger demographics seeking alternative treatments.",
  "metadata": {
    "format": "insurance_memo"
  }
}